From: RGrannus on
Prices for Brand-Name Drugs Most Used by Medicare Patients Jump Almost
10 Percent

Biggest hike in eight years.
by: Tauren Dyson | from: AARP Bulletin | May 18, 2010

http://www.aarp.org/health/drugs-supplements/info-05-2010/brand_name_drug_prices_jump.html?cmp=NLC-WBLTR-CTRL-52810-F1r-3

Brand-name prescription drug prices have jumped nearly 10 percent in
the past 12 months—the biggest spike in eight years, according to a
new AARP report.

The AARP Rx Watchdog report released this week found that the cost of
prescription drugs most commonly used by those in Medicare rose 9.7
percent over the 12-month period ending in March. The Alzheimer’s drug
Aricept rose by nearly 14 percent, while the heart disease medication
Plavix saw a 10.5 percent jump. Expensive specialty drugs, such as
biologics or injectable drugs, saw a hike of 9.2 percent, the report
found. The inflation rate remained virtually flat during the same
period.

Despite the price increase for brand names, the cost of generic drugs
declined by an average of 9.7 percent. The study found that the
average yearly costs for a person taking three generic medications
dropped by $51, compared with a $706 increase for people taking three
comparable brand-name prescriptions.